Recent data indicate that loss of the protective telomeric capping function leads to active degradation of the telomeric G-strand overhang and DNA ligase IV-mediated non-homologous end joining. These molecular events may contribute to genomic instability early in tumorigenesis. It has long been hypothesized that dysfunctional telomeres are recognized as DNA double-strand breaks (DSBs), and when recognized as such, are subject to DSB repair activities. Until recently, however, the pathway mediating the aberrant repair of dysfunctional telomeres was not defined. Previous studies showed that, in cells with diminished TRF2 function, the appearance of new telomeric restriction fragments of a size consistent with fused telomeres coincides with the presence of telomere associations cytogenetically. But whether these novel telomeric fragments are generated by ligation of telomeric strands or by non-covalent nucleic acid interactions, perhaps involving the telomeric G-strand overhangs, has remained an open question.
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Resolving this issue, Smogorzewska et al. [3] found that the novel telomeric fragments were still seen under denaturing conditions, arguing strongly against their being caused by non-covalent nucleic acid interactions. Furthermore, unlike terminal telomeric restriction fragments, the new telomeric fragments were not sensitive to the exonuclease Bal31, indicating that the telomeric repeats are not at the physical end of these fragments. This implies that the chromosome end fusions observed cytogenetically when telomere end protection fails are created by the actual ligation of the G-rich strand of one telomere to the Crich strand of another telomere.
The inference that chromosome end-to-end fusions reflect telomere-telomere ligation raises the obvious question of which repair pathway is acting on these dysfunctional telomeres? Because of the uniform directionality of telomeric sequences -the G-rich strand always proceeds 5′-to-3′ -homologous recombination would fail to give rise to covalently fused telomeres. In contrast, non-homologous end joining (NHEJ) would be predicted to give rise readily to the observed structures. The new observation [3] that mouse cells lacking DNA ligase IV -the ligase that mediates NHEJ -fail to accumulate telomere fusions in response to diminished TRF2 function indicates that NHEJ is indeed the culprit.
Similarly, the Ku heterodimer, another component of the NHEJ pathway, was recently shown to be required for the fusion of critically short telomeres that arise in telomerase-deficient mouse cells [6] . The Ku story is a bit more complex, however, because this essential player in the NHEJ pathway is also a component of telomeric chromatin, and is itself required for normal chromosome end protection [7] [8] [9] . But unlike Ku, DNA ligase IV does not play a role in normal telomere metabolism. Hence the results presented by Smogorzewska et al. [3] expand the role of the NHEJ pathway by demonstrating its activity at ends that retain their complement of telomeric DNA. Thus, loss of a protein component of the protective cap may be sufficient for the chromosome ends to be recognized as DSBs and acted upon by the NHEJ machinery. It is this key event that generates the dicentric chromosomes, which secondarily contribute to genomic instability.
Still, the conundrum remains: how are certain components of the NHEJ pathway, such as Ku, required for both chromosome end protection and fusion of chromosome ends when capping function is lost? Presumably, the activities of these components are influenced by other telomere-associated factors, as has been observed for Ku in fission yeast [10] . Furthermore, fusions in Ku-deficient mouse cells appear to occur independently of G-strand overhangs [9] , suggesting a fundamental difference from the con-sequences of TRF2 deficiency (see below). Thus, it will be important to establish whether the telomere end-to-end associations observed cytogenetically in Ku-deficient cells are similarly caused by covalent ligation of chromosomes rather than non-covalent nucleic acid interactions, for example involving the G-strand overhang.
Because of the dynamics of the DNA structure at chromosome termini during the cell cycle, determining whether leading and/or lagging strand telomeres are subject to end-to-end fusions, and in which phase(s) of the cell cycle fusions occur, has specific implications for models of the mechanism of chromosome end protection. Chromosome replication by the conventional DNA replication machinery gives rise to a blunt end on the leading strand telomere, whereas, removal of the RNA primer of the ultimate Okazaki fragment is predicted to leave a short G-strand overhang on the lagging strand telomere. Yet, long Gstrand overhangs are detected at human chromosome termini regardless of whether they are products of leading or lagging strand synthesis, or whether the cells are actively dividing or quiescent, implicating a processing activity in generating functional telomere ends [11, 12] .
Using a technique called chromosome orientation fluorescence in situ hybridization, Bailey et al. [13] examined the specific ends engaged in fusion events. This technique allowed them to differentiate termini generated by leading versus lagging strand DNA replication machinery. Using the same dominant-negative form of TRF2 as the de Lange group, they found that fusion events were restricted to telomeres replicated by leading strand synthesis; fusions leading to lagging strand termini, as would occur between sister chromatids, or fusions between two lagging strand termini were not observed. Furthermore, because of the absence of chromosome type fusions, the fusion events appeared restricted to the post-replicative phase of the cell cycle (Figure 1) . These results suggested a model in which TRF2 provides end protection specifically to leading strand telomeres following DNA synthesis, perhaps secondary to a role in post-replicative processing of the leading strand telomere blunt ends.
Smogorzewska et al. [3] , however, obtained a different set of results. They found that sister chromatid type fusions were readily detected in cells expressing the dominant-negative form of TRF2, indicating that TRF2 prevents fusion of telomeres regardless of whether they are the product of leading or lagging strand synthesis (Figure 1 ). This is an important observation, because sister chromatid fusions might initiate steps toward gene amplification, which is observed in human tumors (reviewed in [1] ). Even more striking was the presence of chromosome type fusions in the metaphase spreads, raising the possibility that TRF2 is also required to protect chromosome ends prior to DNA replication (Figure 1 ).
To address this question, Smogorzewska et al. [3]
went on to show that chromosome type fusions could still be detected when the period of telomere dysfunction and observation was restricted to a single cell cycle, eliminating the possibility that chromosome type fusions are replicated descendents of chromatid type fusions from the previous cell cycle. Additionally, the fused telomeric restriction fragments observed in cells with diminished TRF2 function were still seen even if the cells were prevented from progressing through S phase, indicating their formation prior to DNA synthesis. And thus, a model emerges with TRF2 as an equal opportunity protector, required at both leading and lagging strand termini and both before and after DNA synthesis.
What accounts for the striking differences between the two studies [3,13]? Perhaps they reflect differences in the DNA damage checkpoint status, function of the NHEJ machinery, or even telomere structure, in the primary human fibroblasts used by Smogorzewska et al. [3] versus the human fibrosarcoma cell line used by Bailey et al. [13] . Uncovering the differences between the two model systems should present an excellent opportunity to further dissect the molecular requirements for fusions at deprotected chromosome ends. As mentioned earlier, telomeres are normally processed to generate long G-strand overhangs. This structural feature has been at the core of many models of telomere end protection. At the most simplistic level, the very presence of a G-strand overhang might serve as a protective mechanism against endto-end ligation by DNA ligase IV, and loss of telomere end protection might reflect loss of the G-strand overhang. In fact, it is striking that the profound end protection defect in cells with diminished TRF2 function is not associated with a detectable loss of duplex telomeric DNA [5] .
Considering the possibility that TRF2 may be involved in preventing loss of the protective G-strand overhang, Smogorzewska et al. [3] observed a reduction in G-strand overhang abundance in G0 arrested cells following TRF2 inhibition. Given this reduction could not be attributed to passive loss during DNA replication or to TRF2 being involved in post-replicative telomere processing, this result pushes forth the model that a key function of TRF2 is to protect the terminal Gstrand overhangs from active nucleolytic processing.
How exactly does TRF2, a telomeric double-stranded DNA binding protein, mediate protection of the singlestranded terminus? One possibility relates to the t-loop, a lariat-like structure present at both ends of mammalian chromosomes, which appears to be generated by cis-invasion of the terminal G-rich overhang into the telomeric duplex tract [14] . In vitro studies have implicated TRF2 in t-loop formation [14, 15] , and so one model proposes that, in the absence of TRF2, the terminal overhang is no longer sequestered by the t-loop, and becomes susceptible to recognition and processing as DNA damage [14, 16] . Alternatively, TRF2 might recruit the telomeric single-stranded DNA binding protein, POT1 [17] , to the chromosome terminus, which then mediates end protection. Studies of interactions between TRF2 and POT1, and of the contribution of POT1 to chromosome end protection in human cells should therefore be of great interest.
Focus on the molecular events described above has been driven by the prediction that the chromosome end fusions generated as a consequence of telomere dysfunction could secondarily give rise to chromosomal instability. For example, non-reciprocal translocations and deletions could arise as a consequence of the recombinogenic DSBs created by rupture of dicentric chromosomes during mitosis (reviewed in [1] ). This prediction was born-out by the detection of an array of non-reciprocal translocations and terminal deletions in human cells shortly after inhibition of TRF2 function [3] . Similar results were observed in mouse cells when examining the consequences of telomere shortening due to a telomerase deficiency [18] . Thus both models of telomere dysfunction, either through loss of TRF2 function or telomere attrition, lend strong support to the hypothesis that telomere dysfunction may contribute to the chromosomal instability observed early in human cancer progression.
